PRACTICE Guidelines REGISTRATION PLATFORM
News MORE
  • 2023.0306

    The Development of Reporting Guideline of clinical Practice Guidelines in General Practice provides detailed guidance for the makers and writers of the general practice guidelines, which will further improve the reporting quality of the general practice guidelines, especially the Chinese general practice guidelines, and promote the application in general medical practice, thus finally improving the quality of primary medical care.

  • 2023.0220

    Professor Gordon Guyatt of McMaster University and Professor Victor Montori of the Mayo Clinic jointly published a paper in the British Medical Journal (BMJ) entitled: Guidelines should consider clinicians' time needed to treat on January 3, 2023.

  • 2022.1126

    IGEST is a generic tool for screening guidelines for any specialty, target population, and healthcare organization, but it is intended only as a screening tool, primarily for quickly assessing guideline quality and determining whether they can be adopted or adapted in other settings, and is not a substitute for some of the more complex guideline quality evaluation tools.

  • 2022.1031

    In July 2022, Jose F. Meneses-Echavez et al. from the Norwegian Institute of Public Health published an article in the Journal of Clinical Epidemiology entitled "Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations". The aim of this study was to identify and describe the processes suggested for the formulation of healthcare recommendations in healthcare guidelines available in guidance documents.

Register MORE
  • 2024.1017
    正常高值血压也称临界高血压,是指血压在正常血压至确诊高血压之间的血压值,即收缩压120-139mmHg,舒张压80-89mmHg。高血压是最常见的慢性病之一,也是心脑血管病最主要的危险因素,可导致脑卒中、心力衰竭及慢性肾脏病等主要并发症,严重影响病人的生存质量,给家庭和国家造成沉重负担。在原发性高血压诊断成立之前,患者一般都会经过一个或长或短的过渡时期,即正常高值血压,此时各重要器官,如心、脑、肾无器质性损害,但易发展成高血压病。临床观察表明,正常高值血压者约有71.5%的人易发展成高血压,正常高值血压者最后发展为确诊高血压的可能性比正常血压者高出2-5倍,而正常人只有11.1%。心血管并发症的患病率及病死率比正常血压者高二倍以上。其并发脑出血、脑血栓、冠心病等,以及死亡率与高血压病人相近,且明显高于正常人。由于它早期没有器质性损害,又缺乏特异症状和体征,所以极易被忽视。防治战略前移是当前临床医学的发展趋势,正常高值血压是高血压病的第一战场。尽管目前已有《高血压》《眩晕病(原发性高血压)》指南,但是尚无针对正常高值血压的共识或者指南。基于此,特此制定本共识,旨在提高人们对正常高值血压的认知,进一步规范临床正常高值血压的中国民族医药疗法的治疗,明确中国民族医药相关方法的适用范围,提高中国民族医药诊疗正常高值血压的临床疗效。
  • 2024.1017
    High-energy injuries are bodily injuries caused by excessive kinetic energy generated by various high-risk factors. In recent years, with the increasing frequency of severe high-energy limb injuries resulting from car accidents, falls from heights, and explosions, the continuous advancement of imaging technologies has played a significant role in the systematic assessment of limb trauma, guiding clinical interventions and improving recovery outcomes. To further guide the clinical evaluation of imaging in high-energy limb trauma, experts in radiology and related fields in China have collaborated to develop this consensus, aiming to enhance the standardized application of imaging analysis and graded assessment in high-energy limb trauma events.
  • 2024.1017
    Photobiomodulation therapy (PBMT) has emerged as a vital modality in modern dermatology, particularly in therapeutic and aesthetic applications. PBMT has demonstrated significant efficacy in reducing wrinkles, improving hyperpigmentation, and alleviating inflammatory skin disorders. To standardize the clinical application of PBMT in dermatology, the Expert Consensus Group on PBMT in Dermatology has formulated this consensus, based on the latest research advancements while considering the specific healthcare context in China. This consensus provides evidence-based recommendations on PBMT’s mechanisms of action, indications and safety, aiming to guide clinical practice and foster the sustainable development of the subspecialty of aesthetic dermatology.
Registration process and operational mode of a CPG registry